Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR mutations were found in additional lung cancer samples from U.S. patients who responded to gefitinib therapy and in a lung adenocarcinoma cell line that was hypersensitive to growth inhibition by gefitinib, but not in gefitinib-insensitive tumors or cell lines.
|
15118125 |
2004 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.
|
16140919 |
2005 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR mutation was significantly correlated with gender, smoking status, pathological subtypes, and differentiation of lung cancers.
|
16199108 |
2005 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR mutations occur in highly selected subpopulations of lung cancer patients: adenocarcinoma histology, never-smoker status, East Asian ethnicity and female gender.
|
16231326 |
2006 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermal growth factor receptor (EGFR) gene mutations are frequently detected in lung cancer, especially in adenocarcinoma, in females, and non-smoking patients.
|
16503085 |
2006 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.
|
16510849 |
2006 |
Malignant neoplasm of lung
|
0.600 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer: impact of primary or secondary mutations.
|
16764754 |
2006 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermal growth factor receptor mutation testing in the care of lung cancer patients.
|
16857818 |
2006 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR mutations were detected by both DHPLC procedure and direct sequencing using lung cancer tissue samples obtained from 97 patients (81 surgical specimens and 16 pleural effusions of non-resectable lung cancer patients).
|
16947044 |
2007 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.
|
17001163 |
2006 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
|
17052295 |
2006 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermal growth factor receptor mutations in lung cancer.
|
17318210 |
2007 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinib.
|
17332364 |
2007 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR kinase domain mutations - functional impact and relevance for lung cancer therapy.
|
17353898 |
2007 |
Malignant neoplasm of lung
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Epidermal growth factor receptor (EGFR) is a transmembrane receptor overexpressed in high percentage lung cancers, and contributes to tumor growth.
|
17643093 |
2007 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR insertion mutations at exon 20 were found from 7 of 322 (2.17%) lung cancer patients.
|
17686547 |
2007 |
Malignant neoplasm of lung
|
0.600 |
Biomarker
|
disease |
BEFREE |
EGFR tyrosine kinase inhibitors in lung cancer: an evolving story.
|
17716025 |
2008 |
Malignant neoplasm of lung
|
0.600 |
Biomarker
|
disease |
BEFREE |
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
|
18304967 |
2008 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer.
|
18381415 |
2008 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Epidermal growth factor receptor (EGFR) mutations in lung cancer enhance tyrosine kinase activity and increase sensitivity to the EGFR tyrosine kinase inhibitor, gefitinib.
|
18422739 |
2008 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR mutation at C-terminal in lung cancers seemed to be extremely rare, however, this D1012H mutation might be a role in EGFR function.
|
18478265 |
2008 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR-tyrosine kinase polymorphism might be associated with clinicopathological background of lung cancers.
|
18541260 |
2008 |
Malignant neoplasm of lung
|
0.600 |
Biomarker
|
disease |
BEFREE |
EGFR assays in lung cancer.
|
18580100 |
2008 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR mutation status was not correlated with R497KEGFR genotype of lung cancers.
|
18726117 |
2009 |
Malignant neoplasm of lung
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
EGFR mutation status was not correlated with the FGFR4 genotype of lung cancers.
|
18949411 |
2008 |